Controversies in Parkinson’s Disease Webinar Series. Levodopa: Friend or Foe?
Wed, Aug 25 | https://vcuhealth.zoom.us/webinar/register/

Controversies in Parkinson’s Disease Webinar Series. Levodopa: Friend or Foe?

In this webinar, we will discuss the rationale for both beginning Levodopa at the onset of diagnosis versus delaying the use of medication.
Registration is Closed

Time & Location

Aug 25, 1:00 PM – 2:00 PM
https://vcuhealth.zoom.us/webinar/register/

About the Event

Join the Parkinson’s and Movement Disorders Center for conversations and audience Q&A with specialists whose research and clinical expertise focus on Parkinson’s Disease. With and introduction by Brian Berman, Director of the Parkinson’s and Movement Disorders Center, the session will be moderated by exercise and wellness advocates from Power Over Parkinson’s and Leslie Cloud, MD, Director of the Parkinson’s Disease Program at the VCU Parkinson’s & Movement Disorders Center. Levodopa is the most effective medication for managing the motor symptoms of Parkinson’s disease; nevertheless, quite a bit of controversy exists about the ideal time to initiate levodopa therapy. Some physicians believe that it should be the drug of first choice for everyone, while others prefer to rely on other medications for as long as possible before starting levodopa. In this webinar, we will discuss the rationale for both treatment paradigms.

Share This Event